Linklaters has advised Bridgepoint Capital for the first time in London, acting on the buy-out house’s acquisition of Gambro Healthcare.
The City giant, which has a relationship with the client in Stockholm and Paris, advised on the acquisition of the dialysis care services division of Swedish-based Gambro Group for an undisclosed sum. Press reports have put the value of the deal as high as €600m (£407.5m). The business is the second-largest of its type in Europe and has 155 clinics across 14 countries.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]